The multifunctional adhesive glycoprotein vitroneain (VN) undergoes a unique conformational transition from the plasma form into a multimedc form that represents the reactive heparin-binding form. In this study we investigated the interaction of multimedc vitronectin (VNmult) or VN-gold conjugates (which are equivalent in biochemical properties) with confluent and subconfluent monolayers of porcine endothelial cells. Time-dependent direct binding of radiolabeled V'Nmdt to the luminal face of endothelial cells at 37°C was observed which was competed by heparin, whereas plasma VN showed hardly any binding. At 4'C binding of VNmdt remained cell-associated, whereas after 6 hr at 37°C a major portion of the ligand was translocated through cells and was associated with the subcellular matrix. Cytochemical studies with VN-gold conjugates were performed to demonstrate uptake of VNmdt. At 4°C only surface decoration of cells with gold label was seen, which was totally reversible in the presence of heparin. Subsequent incubation for &-ous time intervals at 37°C revealed disappearance of gold label from the surface and accumulation of conjugates in a perinuclear dismbutioninside the cells as judged both by electron microscopy and after silver enhancement by light microscopy. Cross-sections of endothelial cells demonstrated the inclusion of VN-gold conjugates in coated pits, endosomes, and in lysosomal compartments close to the nucleus. Within 2-6 hr a portion of VN-gold conjugates had a mmulated with proteoglycans at the matrix face. These data provide strong evidence for specific routing of a portion of V N m d t from the circulation into extravascular spaces, where the protein is believed to fulfii major adhesive and regulatory functions particularly as co-factor in plasminogen activation and immune defense. (J Hisrochem Cytochem
Introduction
Vitronectin (VN) is a multifunctional adhesive glycoprotein present mostly in the circulation of vertebrate organisms and associated with different extracellular matrices. VN has been implicated from in vitro studies to fulfill different physiological functions in defense mechanisms (Preissner and Jenne, 1991; Tomasini and Mosher, 1990) . In contrast to in situ biosynthesis of collagens, fibronectins, or other matrix proteins, which represent typical structural elements of basement membranes or extracellular matrices, biosynthesis of VN is mainly restricted to liver hepatocytes (Seiffert et al., 1991; Barnes and Reing, 1985) . Consequently, VN at distant sites in the body such as extracellular matrix of muscle, embryonic lung (Hayman et al., 1983) . vascular wall (Guettier et al., 1989; Rus et al., 1987) , in association with elastic fibers in skin (Dahlback et al., ' Supported by grant Vi SFB 3101B6 and in part by grant Pr 327/1 from the Deutsche Forschungsgemeinschaft (Bonn, Germany) and is part of the PhD thesis of SH at the Justus-Liebig-Universi~at, Giessen (Germany). * Correspondence to: Dr. Klaus T Preissner, Haemostasis Research Unit, MPI, Sprudelhof 11, Germany. 1986) or different fibrotic tissues (Reilly and Nash, 1988) or elsewhere has been proposed to originate from the plasma pool. At present, mechanisms of possible translocation and deposition of VN at these extracellular sites are unknown.
A number of protein-protein interaction sites and characteristic ligand-binding domains have been identified in the VN molecule. The major portion of plasma VN exists as an internally folded and stabilized molecule (latent form) which may undergo unique conformational transition into a heparin-binding form present in the circulation only in minor quantities (Izumi et al., 1989) . In vitro this form of VN may self-associate into multimers (VNmult) (Stockmann et al., 1993) . The particular interaction of VN with terminal components of the complement cascade (Tschopp et al., 1988; Podack and Muller-Eberhard, 1979) and with components of the plasminogen activation system (Declerck et al., 1988; Preissner, 1990 ) points to relevant physiological features of the adhesive protein in the protection of uncontrolled cell lysis (complement) and regulation of pericellular proteolysis (hemostasis), respectively. After activation VN becomes incorporated into oligomeric complexes together with endproducts of both cascade systems and is present in measurable quantities as VN-C5b-9 (Hugo et al., 1987) 1823 or VN-thrombin-anti-thrombin 111 complex (de Boer et al., 1993) in plasma. In these complexes VN exists in the heparin-binding form (de Boer et al., 1992; Tschopp et al., 1988) , such that the latter ternary complex may interact in a heparin-dependent manner with the luminal face of the endothelium.
Based on previous studies from our laboratory which demonstrated physical and functional dfirences between plasma VN and VNmult in specific binding to adhesive cells ( S . Hess et al., manuscript in preparation) , in this work we used the colloidal gold labeling technique to follow the fate of in endothelial cells by light (LM) and electron microscopy (EM). Binding of VN-gold conjugates appeared to be solely dependent on heparin-like structures of the luminal face of the endothelium, and subsequent metabolic processing of VN by these cells may occur by either an endocytotic or a transcytotic pathway, finally leading to deposition of a portion of VN in association with proteoglycans (PGs) at the basolateral face of the cells. By a combination of cytochemical methods and direct binding experiments, these data give first in vitro evidence on the binding of preferentially V N m d t to vascular endothelial cells and on the routing of the adhesive protein towards the extravascular space.
Materials and Methods
Materials. Heparin (lot 51H0480) isolated from porcine intestinal mucosa, bovine serum albumin (BSA), uansferrinlselenite supplement, polyclonal antibodies against human fibronectin, and other chemicals of analytical grade were purchased from Sigma (Munich, Germany) unless otherwise stated. Cell culture dishes were obtained from Nunc (Wiesbaden, Germany) or Costar (Cambridge, MA), fetal calf serum (FCS) was from Gibco (Karlsruhe, Germany), and reagents for electrophoresis were obtained from Bio-Rad Laboratories (Munich, Germany). Nitrocellulose was from Schleicher & Schiill (Dassel, Germany) and carrier-free ['251]-Na was from Amersham (Braunschweig, Germany).
VN was purified from human plasma in its latent form as previously described (Preissner et al., 1985) and converted into VNmult by incubation in Tris-buffered saline, pH 7.4, containing 6 M urea for 1 hr at 37'C, followed by exhaustive dialysis against the same buffer without additive. Both forms of VN were labeled with [ '''II-Na by the iodogen procedure (Fraker and Speck, 1978) as outlined elsewhere , resulting in specific activity of 2.8-4.2 x lo6 cpmlM. Monoclonal antibody (MAb) 16A7 against human VN was obtained by standard hybridoma techniques and was kindly provided by Dr. Paul Declerck (Center for Thombosis and Vascular Research, University of Lcuven, Belgium). Generation and identification of MAb TSPlOl against thrombospondin has been described elsewhere (Winnemoller et al.. 1992) .
Cell Culture. Endothelial cells were isolated from porcine aortic tissue as previously described (Vischer and Buddecke, 1985) . Cells were grown at 37'C in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS. For direct binding experiments, cells were seeded into 48well tissue culture plates and confluent cell cultures of passage 2-6 were taken. For cytochemical experiments confluent and subconfluent cell cultures of the second and third passage in 35-mm tissue culture plates were used.
For direct binding experiments with radiolabeled VN, cells (0.8-1 x 10' /well) were incubated for 16 hr with serum-free medium containing antibiotics and 0.5 % (wlv) BSA, 20 pglml insulin, 20 pglml transferrin, and 20 nglml selenite. After two washes with BSA-containing serum-free medium, cells were incubated with 3-5 nM radiolabeled VN (plasma form, multimeric form) in serum-free medium containing 0.2% (wlv) 25 mM HEPES in the absence or presence of competitors such as heparin (0.1 mglml) or GRGDSP peptide (Bachem; Bubendorf, Switzerland) (0.2 mglml) for up to 6 hr at 37°C. After three washes with cold serum-free mediumlBSA, cell layers were solubilized with 1 N sodium hydroxide and counted in a gamma counter. For discrimination between cell-and matrixassociated radioactivity at 4'C and 37°C. cells were gently detached from extracellular matrix by treatment with 0.1% Triton X-lOOlO.2 M ammonium hydroxide for 10 min, and after solubilization of matrix with sodium hydroxide radioactivity in both fractions was measured. Experiments were carried out in triplicate and were repeated at least twice with different batches of radiolabeled VN. Nonspecific binding was determined in the presence of 200-fold molar excess of non-radiolabeled VNmuit and was between 30 and 45% of total binding. Vitronectin-Gold Conjugation. Colloidal gold particles (17 nm) were prepared by reduction of tetrachloroauric acid solution as described (Frens, 1973) . The gold suspension was concentrated about 60-fold by centrifugation at 13.000 x g. For conjugation, 0.2 ml of this gold suspension was diluted 1:10 with doubled-distilled water (absorbance at 520 nm 2.5) at pH 5.6, and about 14 pg VN/ml gold suspension was used for coupling. The VN-gold complex was stabilized with 50 mM HEPES buffer, pH 7.2, but no other stabilizers were used. Monodispersity of the gold particles was Vitronectin-Gold Binding and Uptake Experiments. Cell cultures were pre-incubated for 30 min with medium (DMEM, 1% BSA, 20 mM HEPES) which was changed twice before the cells were incubated with this medium containing 150 pllml of VN-gold suspension. After 2 hr at 4°C the labeling medium was removed and the cell layer was washed three times with ice-cold DMEMlBSA and finally fwed with 1% formaldehyde/O.l% glutaraldehyde in PBS. Nonspecific binding was determined by incubation of the cells with BSA-gold conjugate and by competition of VN-gold binding by heparin (10 pglml). For uptake studies cell cultures were incubated with the gold conjugates at 4 ' C . washed as above, and post-incubated for Varous periods of time at 37°C to allow uptake ofsurface-bound VN-gold complexes. All experiments were carried out in duplicate in three separate experiments.
Silver Enhancement. The goldlsilver intensifier kit was prepared as follows. Silver nitrate (1.5 g) was dissolved in a mixture of 900 ml of deionized water and 100 ml of 1.2-propandiol. The developer solution was prepared by dissolving 4 g hydrochinone in 1000 ml citrate buffer. pH 4.5, containing 0.1% formaldehyde and 200 ml of 1.2-propandiol. Silver enhancement of bound and internalized gold marker was performed as follows. An unlabeled control and the labeled cell cultures were chemically fixed and thoroughly washed with deionized water. A freshly prepared mixture of equal parts of the two liquid components of the kit was added to the culture dishes. Development was performed at 15-18' C on a tumbling plate at moderate room illumination and was occasionally controlled with an inverted microscope. After 20 min the development was stopped by washing with deionized water. Usually the procedure was repeated once to enhance the signal. The development was stopped when nonspecific silver precipitates appeared in the unlabeled control. The specimens were photographed in an inverted microscope (Zeiss IM, Oberkochen, Germany) under brightfield and phase-contrast illumination without prior counterstaining.
Electron Microscopy. Ultra-thin sections from protein-gold-labeled cell cultures were investigated in a transmission electron microscope (Phillips EM 201; Nijmegen, The Netherlands). After fixation, cell monolayers were stained either with 2% (wlv) os04 for overall visualization of structures or with 1% (wlv) cuprolinic blue (Promochem; Wesel, Germany) for detection of PGs according to the method of Scott (1985) . followed by dehydration with ethanol, detachment with propylene oxide, and embedding in epoxy resin as described previously (Volkcr et al., 1991) . To study the topographic distribution of VN-gold marker on the cell surface, the platinumlcarbon replication technique was applied as described earlier (Moor and Muhlctaler, 1962) . In the EM, the basolateral surface of cells was identified by its close proximity to the substrate, a thin coat of adhesive material originally attached to the bottom of the culture dish. For each cxperiment presented at least 100 cells in about 50 ultra-thin smionswere acamined and representative micrographs were taken.
Other Methods. After radiolabeling, both forms of VN were analyzed on non-denaturing polyacrylamide gels (5-8%) using the buffer system of Laemmli (1970) without sodium dodecylsulfate. Discrimination between both forms of VN with MAb was performed as described elsewhere (Stockmann et al., 1993) . Binding of heparin to VNmulr was carried out essentially as reported before (Kost et al.. 1992) . VN in association with colloidal gold was analyzed for conformational change with MAb 16A7, which recognizes the multimeric form but not the plasma form of the adhesive protein. Bridly, anti-VN 16A7 (10 pl each of 1. 0.1, 0.01 mglml) or antithrombospondin (10 pl of 1 mglml) were adsorbed onto BSA-pre-coated nitrocellulose in a dot-blot chamber (Bio-Rad). followed by incubation with VN-gold suspension at 14 pglml in 50 mM HEPES buffer, pH 7.4, containing 1% (wlv) BSA for 20 min at 25°C. Subsequent silver enhancement was carried out with parallel Ntrocellulose strips: the dried strips were dirmly photographed.
Results

Binding of Vitronectin to the Endothelial Cell Monolayer
Direct binding of both forms of radiolabeled VN (latent plasma form and heparin-binding multimeric form) at 37% to confluent monolayers of cultured porcine endothelial cells derived from aorta was compared. Utilizing the same input of specific radioactivity, binding efficiency of VNmult proved to be three to four times higher, resulting in a significantly larger amount of multimeric ligand bound per well (Figure 1A) . Moreover, binding of V N m u l t was competed to more than 60% by heparin, while RGD-containing peptide had no effect, indicating the involvement of the heparinbinding domain ofVN in cell surface interaction. Moreover as outlined elsewhere (S. Hess et al., manuscript in preparation), pretreatment of cells with glycanases or pre-incubation in the presence of D-D-xyloside resulted in a similar degree of reduction of binding of VNmult. To discriminate between binding to cells and to the underlying extracellular matrix, binding of a different batch of V N m u l t was compared at 4°C and 37°C. Whereas at 4°C hardly any association of the radiolabeled ligand with the matrix was noted after interaction with the confluent cell monolayer, at 37°C the major portion of VNmult was bound to the extracellular matrix, indicating metabolism-dependent translocation of VN through the cell layer (Figure 1B) .
The (latent) plasma form of VN and the heparin-binding multimeric form not only differ in their reactivity with cell surfaces, as demonstrated here, but exhibit drastic differences in molecular mass distribution, as judged by non-denaturing gel electrophoresis (Figure 2A) . Whereas plasma VN consists predominantly of monomeric and dimeric forms, multimeric VN represents a population of oligomers 15-25 nm in diameter and is recognized by conformation-dependent MAb 16A7 (Stockmann et al., 1993) , as shown in was not recognized by the antibody (Figure 2C ). To test whether adsorption to colloidal gold generates the conformation of VNmuit, binding to VN-gold conjugates to different concentrations of MAb 16A7 was carried out. Since VN-gold complexes were detected by immobilized 16A7 (Figure 2B) , it is plausible to assume that the heparin-binding form of VN is present in these conjugates. In addition, the majority of VN-gold conjugates bound to immobilized heparin. No reactivity was seen with antibodies against thrombospondin. Assuming a Stoke's radius of 3.9 nm (Preissner et al., 1985) approximately 18 VN molecules were calculated to be adsorbed to the 17-nm gold particles. Therefore, there is good evidence to believe that VN-gold complexes resemble in both their functional properties and their dimensions the multimeric form of the adhesive protein.
Binding of VN-GoZd Conjugutes to the EndotbeZiaZ CeZZ MonoZuyer
To complement direct binding experiments previously outlined, binding of VN-gold conjugates to subconfluent monolayers of cultured aortic porcine endothelial cells was studied by LM. Labeling of cells for 1 hr at 4°C resulted in decoration of the apical cell surface with a random distribution of gold complexes, particularly .-..
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visualized by LM after silver enhancement. The density of labeling was rather variable among individual cells, and compared to 4°C. at 37°C an increase in the number of VN-gold markers was observed. Pericellular areas of extracellular matrix, as seen in subconfluent cultures, were stained most heavily (Figure 3) . It cannot be excluded that both transcytosis and spreading or migration over pre-adsorbed VN-gold account for subcellular accumulation. In the absence of VN-gold conjugate and in the presence of heparin during binding of VN-gold complexes, negligible background staining or almost complete lack of staining, respectively, was observed. Since under these conditions reduction in VN-gold complex binding to extracellular matrix is also seen, heparin-dependent ligand binding to both cells and (free) matrix appears to be plausible. As seen in experiments with BSA-gold conjugates, unspecific labeling of cell surface/extracellular matrix was very low (Figure 3) .
These findings were complemented by EM. Electron micrographs of platinumkarbon replicas of subconfluent cell monolayers after binding at 4°C revealed association of VN-gold conjugates with the apical surface in clusters (80-100 per 100 pm2). whereas free extracellular matrix was most heavily stained (Figure 4) . The distribution of clusters was rather irregular, varied in size between 150 and 500 nm. and more important, association of VN-gold conjugates was inhibited by heparin, compatible with findings from previous experiments using radiolabeled ligand.
Binding of VN-gold conjugates was particularly confined to microvilli of endothelial cells at cell-cell interaction sites, demonstrated by platinumkarbon replicas of the cell surface and by ultrathin sections of cells (Figure 5 ) . Whether these findings indicate a participation of exogenous VN in cell-cell contact interactions in monolayers of cells remains to be established. In subcellular areas, VN-gold conjugates bound to fibrillar and PG-rich parts of the extracellular matrix, as demonstrated by counterstaining with cuprolinic blue (Figure 5 ) .
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Metabolism of VN-Gold Conjugates in Endothelial Cells
The fate of VN-gold conjugates was followed by analyzing cell monolayers at different time intervals of post-incubation at 37°C. Time-dependent uptake of complexes was visualized by silver enhancement ( Figure 6 ) and by direct inspection of confluent monolayers by EM in vertical cross-sections (Figure 7) . After 15 min of post-incubation at 37°C the partial disappearance of VN-gold conjugates from the cell surface was already noted, and subsequently intracellular accumulation in a perinuclear fashion occurred (Figures  6 and 7) . Later time points of post-incubation indicated a further increase in the amount and size of intracellularly located silver granules, and after 2 hr of post-incubation intracellular concentration of complexes was maximal.
Likewise, inspection of ultra-thin sections of endothelial cells . .
by EM supported the previously noted findings and revealed that clusters of VN-gold were concentrated in coated pit structures, subsequently appeared in endosomes, and after 90 min of postincubation in multivesicular bodies (Figure 7) . Finally, after 2 hr at 37°C gold particles were found in lysosomes or already at the basolateral side of the cells (see Figure 5 ) .
Discussion
From several histological studies using different antibody-based detection systems it is apparent that extravascular localization of VN in the mammalian organism is confined to the extracellular matrix of blood vessels and other extravascular tissue structures (for review see Preissner, 1991) . Since the main site of biosynthesis of VN is liver cells and only a very limited number of non-hepatic cell types are able to biosynthetically process the adhesive protein, it appears plausible to assume that VN deposited in extravascular spaces originates from the plasma pool. The age-related accumulation of VN in association with elastic material in the dermis (Dahlback et al., 1989 ) supports this hypothesis. Moreover, in vitro studies from our laboratory have indicated that adhesive cells preferentially bind the heparin-binding form (VNmult) (S. Hess et al., manuscript in preparation) . Whereas the majority of circulating plasma form of VN represents a rather latent molecule, both VNmult and VN in the ternary complex share a similar heparinbinding conformation whereby VNmult is considered to be the prototype conformer of this type. In the present study the critical steps of interaction of VNmult with endothelial cells have been unraveled with LM and EM techniques.
In initial experiments it was ascertained that VNmult and VN-gold conjugates are similar if not identical in their recognition by the conformation-dependent MAb 16A7 and in characteristics of cell binding. In fact, in both cases, initial binding of VNmult (VN-gold) was saturable around 2 hr at 4"C, displaceable by excess of unlabeled ligand and by heparin, indicating specificity of binding involving heparin-like cell surface molecules. Although other heparin-dependent cell surface-associated binding sites may be involved, our results (including heparinase treatment) argue in favor of heparan sulfate PG-type interactions with VNmult. At cell-free areas, a considerably higher decoration (of extracellular matrix) by VN-gold was found, which was significantly reduced in the presence of heparin indicating the involvement of matrix-PG moieties in these interactions as well. Likewise, direct binding of radiolabeled VNmult to isolated extracellular matrix of endothelial cells was about fourfold higher compared with cells and was blocked by more than 90% in the presence of heparin (data not shown). VN-gold marker in a coated pit (CP); the arrow points to cuprolinic blue precipitates in close association with VN-gold marker. (c) After cytochemical labeling at 4% and Dost-incubation for another 15 min at 3PC. the gold marker is seen et al., 1981) have been described to bind to the luminal face of these cells involving certain types of PGs. Some cited studies have also been performed with aortic porcine endothelial cells, which express these surface structures at an appreciable degree. As revealed by LM and EM inspection, heparin blocked labeling of cell monolayers with VN-gold at 4"C, suggesting the involvement of PGs in binding to VNmult as well. The ternary complex VN-thrombin-anti-thrombin I11 had similar binding characteristics with endothelial cells and was also inhibited by a synthetic peptide representing the heparin-binding domain of VN (de Boer et al., 1992) . Whether similar recognition structures are involved as described for the binding of thrombospondin (Volker et al., 1991; Murphy-Ullrich and Mosher, 1987) or lipoprotein lipase (Saxema et al., 1991) to endothelial cells remains to be established.
The initial clustering of VN-gold decoration of endothelial cells was similar to that described for thrombospondin (Volker et al., 1991) , but clusters of VN-gold were also concentrated at cell-cell contact sites along the microvilli protrusions between cells where multiple surface binding sites may keep VNmult trapped. Although decoration by VN-gold at these contact sites was specific and inhibited by heparin, it is unclear at present whether PG structures are concentrated along microvilli and whether trapping of VN participates in mediating cell-cell contacts. Interestingly however, recent observations point to a possible role of integrins (including bytype receptors) in maintaining cell-cell contacts (Lampugnani et al., 1991) . Although also present at the luminal face (Conforti et al., 1992) . bytype integrins including the VN receptor appear not to be in a ligand-binding state, since neither plasma VN nor VNmuIt or the ternary complex (de Boer et al., 1992) showed interaction via RGD-dependent mechanisms with endothelial cell monolayers. In contrast, human endothelial cells in suspension recognized and bound plasma VN in an RGD-dependent manner , subsequently leading to efficient cell adhesion and spreading, indicating the functional availability of integrins in trypsinized cells.
As demonstrated in this study, processes during post-incubation of VN-gold-decorated cell monolayers at 37°C included (a) concentration of VN-gold conjugates in higher clustered structures, (b) total disappearance of gold decoration from the luminal face of the cells, (c) uptake of VN-gold into the endosomal compartment with concentration in a perinuclear fashion, and (d) translocation to lysosomal compartments or eventually to the basolateral face of the cells. These events were observed within a time period of about 2-6 hr. implying that a typical receptor-mediated endocytosisltranscytosis process involving initial demonstrable coated pit structures had occurred (Simionescu et al., 1987) . These initial events were similar to endocytosis of thrombospondin-gold conjugates (Volker et al., 1991) , whereas in control experiments with BSA-gold or in the presence of heparin these subsequent processes could not be demonstrated. Although the sites of binding and internalizain endosomes (E). (d) After 90 min of post-incubation at +C, gold marker is found in multivesicular bodies (MB) and (e) after 3 hr at 37% in lysosomes (L). Bars: a = 0.5 wm; b.c = 0.2 pm; d,e = 1 wm. tion were characterized with the colloidal gold marker, this method aione does not give sufficient widence for transcytotic events. In addition, different cell types may handle gold probes in various ways, leading to different sorting of conjugated and non-conjugated ligands in the endosomal system (van Deun et al., 1986) . Preliminary direct binding studies with VNmult and the ternary complex together with metabolic inhibitors support our findings about the translocational routes of VN-gold and demonstrate the involve-A variety of plasma components, including platelet factor 4, thrombin or thrombospondin (Murphy-Ullrich and Mosher, 1987; Shimada and Ozawa, 1985; Busch et al., 1980) . and endothelial cell products such as lipoprotein lipase (Saxema et al., 1991 (Sivaram et al., 1992) is translocated in a similar fashion to that of VN remains to be shown. It is unclear at present whether and if so which portion of VNmulr may escape translocation to intracellular lysosomal compartments by traversing the cell monolayer through intercellular gaps. VN-gold bound along the microvilli may account for such direct non-degradative translocation. In fact, analysis oftrichloroacetic acid non-precipitable radiolabeled VNmult revealed that only minor amounts of bound ligand were proteolytically modified after 2 hr of processing (S. Hess and K. T. Preissner, unpublished observation) . It also remains to be determined whether differences exist in routing (transcytosis vs lysosomal degradation) between free VNmuit and VN in association with other protein components.
U e n together, the present data provide evidence by direct binding assays and by ultrastructural analysis that multimeric VN (the prototype conformer of VN which has undergone a transition from the latent plasma form into a heparin-binding form) is preferentially recognized possibly by PG-type cell surface structures of vascular endothelial cells. Metabolism of receptor-mediated endocytosed VN may result either in lysosomal accumulation of ligand or in translocation onto the basolateral side of the cells, with subsequent deposition into the extracellular matrix. Since only a minor portion of circulating VN is in the heparin-binding conformation (Izumi et al., 1989) , continuous supply of the subendothelium in the vasculature may account for deposition of the adhesive protein at these sites observed by histochemical analysis, since endothelial cells in particular do not synthesize VN in situ (Seiffert et al., 1990) , as deduced from Northern blotting and polymerase chain reaction experiments (I. Eppendahl et al., manuscript in preparation) . Although this issue seems to be in contradiction to the observation about the presence of VN in endothelial cells by Berge et al. (1992) , their immunohistochemical data may relate to our present findings about endocytosisluanscytosis of VN by endothelial cells and not to de novo mRNA/protein synthesis. Any physiological inducers of the conformational transition of plasma VN into VNmult may indirectly be responsible for subsequent deposition of VN into the extracellular matrix of vessels (and possibly elsewhere). At these sites VN functions as potent adhesive factor, as stabilizing protein for plasminogen activator inhibitor-1 Mimuro and Loskutoff, 1989) , and as modulator of cell growth (Wijelath et al., 1993) . Further studies in vitro and in vivo are required to establish the causal relationships between these regulatory functions of VN in the vessel wall and the clearance and subsequent translocation of VN( -complexes) to these sites.
